Economy & Tech2 months ago
FDA Approves Japanese Alzheimer's Drug, Sparks Important Discussions on the Value of Medicine
Lecanemab is the first drug proven to slow the progression of Alzheimer's. Its manufacturer Eisai calculated its societal value to determine a suitable price.
